Skip to main content
. 2024 Aug 3;17(8):1020. doi: 10.3390/ph17081020

Figure 2.

Figure 2

Impact of common clinical conditions on the composition of the most predominant gut microbial phyla. Data were adapted from public Human Gut Microbiome Atlas databases, available at https://www.microbiomeatlas.org (accessed on 28 May 2024). In this figure, the microbial data were obtained at the phylum level from a total sample size of 1165 samples, comprising 164 samples from subjects with obesity, 71 from subjects with Crohn’s disease, 21 from subjects with ulcerative colitis, 156 from subjects with colon adenoma, 534 from subjects with colorectal cancer, 118 from subjects with non-small cell lung cancer, and 101 from subjects with renal cancers. The corresponding published articles ensure that the necessary ethical approvals regarding data access were obtained. The primary publications included the cohorts from the following bioprojects: Obesity (PRJEB4336); Crohn’s disease (PRJEB15371; PRJEB2054); Ulcerative colitis (PRJEB2054); Colon adenoma (PRJDB4176; PRJEB6070; PRJEB7774; PRJNA447983); Colorectal cancer (PRJDB4176; PRJEB10878; PRJEB12449; PRJEB27928; PRJEB6070; PRJEB7774; PRJNA447983; PRJNA531273); Non-small cell lung cancer (PRJEB22863); Renal Cancer (PRJEB22863).